116 related articles for article (PubMed ID: 9880123)
1. Calcium channel blocker use and the risk of prostate cancer.
Vezina RM; Lesko SM; Rosenberg L; Shapiro S
Am J Hypertens; 1998 Dec; 11(12):1420-5. PubMed ID: 9880123
[TBL] [Abstract][Full Text] [Related]
2. Calcium Channel Blocker Use and the Risk for Prostate Cancer: A Population-Based Nested Case-Control Study.
Rotshild V; Azoulay L; Feldhamer I; Perlman A; Muszkat M; Matok I
Pharmacotherapy; 2019 Jun; 39(6):690-696. PubMed ID: 30917404
[TBL] [Abstract][Full Text] [Related]
3. Inverse association between prostate cancer and the use of calcium channel blockers.
Debes JD; Roberts RO; Jacobson DJ; Girman CJ; Lieber MM; Tindall DJ; Jacobsen SJ
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):255-9. PubMed ID: 14973089
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive drugs and the risk of idiopathic aplastic anaemia.
Myers MW; Vasilakis C; Kaufman MR; Jick H
Br J Clin Pharmacol; 2000 Jun; 49(6):604-8. PubMed ID: 10848725
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive drugs use and the risk of prostate cancer: a meta-analysis of 21 observational studies.
Cao L; Zhang S; Jia CM; He W; Wu LT; Li YQ; Wang W; Li Z; Ma J
BMC Urol; 2018 Mar; 18(1):17. PubMed ID: 29514670
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockers and the incidence of breast and prostate cancer: A meta-analysis.
Thakur AA; Wang X; Garcia-Betancourt MM; Forse RA
J Clin Pharm Ther; 2018 Aug; 43(4):519-529. PubMed ID: 29656432
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive drugs and the risk of incident rosacea.
Spoendlin J; Voegel JJ; Jick SS; Meier CR
Br J Dermatol; 2014 Jul; 171(1):130-6. PubMed ID: 24428524
[TBL] [Abstract][Full Text] [Related]
8. Do calcium channel blockers increase the risk of cancer?
Pahor M; Guralnik JM; Salive ME; Corti MC; Carbonin P; Havlik RJ
Am J Hypertens; 1996 Jul; 9(7):695-9. PubMed ID: 8806983
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blockers and the risk of cancer.
Rosenberg L; Rao RS; Palmer JR; Strom BL; Stolley PD; Zauber AG; Warshauer ME; Shapiro S
JAMA; 1998 Apr; 279(13):1000-4. PubMed ID: 9533498
[TBL] [Abstract][Full Text] [Related]
10. Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women.
Wilson LE; D'Aloisio AA; Sandler DP; Taylor JA
Breast Cancer Res; 2016 Jul; 18(1):61. PubMed ID: 27378129
[TBL] [Abstract][Full Text] [Related]
11. Vasectomy and prostate cancer: a case-control study in India.
Platz EA; Yeole BB; Cho E; Jussawalla DJ; Giovannucci E; Ascherio A
Int J Epidemiol; 1997 Oct; 26(5):933-8. PubMed ID: 9363512
[TBL] [Abstract][Full Text] [Related]
12. Calcium-channel blockers and risk of cancer.
Jick H; Jick S; Derby LE; Vasilakis C; Myers MW; Meier CR
Lancet; 1997 Feb; 349(9051):525-8. PubMed ID: 9048789
[TBL] [Abstract][Full Text] [Related]
13. Using medication history to measure confounding by indication in assessing calcium channel blockers and other antihypertensive therapy.
Leader S; Mallick R; Roht L
J Hum Hypertens; 2001 Mar; 15(3):153-9. PubMed ID: 11317198
[TBL] [Abstract][Full Text] [Related]
14. Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study.
Azoulay L; Soldera S; Yin H; Bouganim N
Epidemiology; 2016 Jul; 27(4):594-601. PubMed ID: 27031042
[TBL] [Abstract][Full Text] [Related]
15. Long-term use of antihypertensive drugs and risk of cancer.
Assimes TL; Elstein E; Langleben A; Suissa S
Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1039-49. PubMed ID: 18780400
[TBL] [Abstract][Full Text] [Related]
16. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
[TBL] [Abstract][Full Text] [Related]
17. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive drug use and the risk of prostate cancer (Canada).
Perron L; Bairati I; Harel F; Meyer F
Cancer Causes Control; 2004 Aug; 15(6):535-41. PubMed ID: 15280632
[TBL] [Abstract][Full Text] [Related]
19. Dihydropiridine calcium-channel blockers and perioperative mortality in aortic aneurysm surgery.
Kertai MD; Westerhout CM; Varga KS; Acsady G; Gal J
Br J Anaesth; 2008 Oct; 101(4):458-65. PubMed ID: 18556693
[TBL] [Abstract][Full Text] [Related]
20. Association between captopril, other antihypertensive drugs and risk of prostate cancer.
Ronquist G; Rodríguez LA; Ruigómez A; Johansson S; Wallander MA; Frithz G; Svärdsudd K
Prostate; 2004 Jan; 58(1):50-6. PubMed ID: 14673952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
